Net Cash Provided by (Used in) Financing Activities in USD of NGM BIOPHARMACEUTICALS INC from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NGM BIOPHARMACEUTICALS INC quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2017 to 2023.
  • NGM BIOPHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was $279,000, a 58% decline year-over-year.
  • NGM BIOPHARMACEUTICALS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,775,000, a 97% decline from 2022.
  • NGM BIOPHARMACEUTICALS INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $54,233,000, a 64% decline from 2021.
  • NGM BIOPHARMACEUTICALS INC annual Net Cash Provided by (Used in) Financing Activities for 2021 was $149,657,000, a 321% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NGM BIOPHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $279,000 -$389,000 -58% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q1 2022 $668,000 -$139,809,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $140,477,000 +$136,886,000 +3812% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $3,591,000 +$3,594,000 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $3,000* +$111,000 +97% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $114,000 01 Jan 2018 31 Mar 2018 10-Q 16 May 2019 2019 Q1

NGM BIOPHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,775,000 -$52,458,000 -97% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2024 2023 FY
2022 $54,233,000 -$95,424,000 -64% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
2021 $149,657,000 +$114,119,000 +321% 01 Jan 2021 31 Dec 2021 10-K 11 Mar 2024 2023 FY
2020 $35,538,000 -$145,213,000 -80% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $180,751,000 +$180,553,000 +91188% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $198,000 -$141,000 -42% 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
2017 $339,000 01 Jan 2017 31 Dec 2017 10-K 17 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.